相关实验视频
Updated: Jul 8, 2025

07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
48.2K
福尔科丁和对神经肌肉阻断剂的过敏:我们在哪里,我们是如何来到这里的?
Louise Savic1, Philip M Hopkins2
1Department of Anaesthesia, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
British journal of anaesthesia
|December 9, 2023
概括
选患者之前使用福尔科丁是不有利于预防神经肌肉阻断剂过敏. 麻醉师可以在临床上必要时安全地使用神经肌肉阻断剂.
科学领域:
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
- 临床过敏 临床过敏
背景情况:
- 福尔科丁与对神经肌肉阻断剂的过敏之间存在潜在的联系.
- 这种关联导致了对麻醉前查的考虑.
研究的目的:
- 为了评估在神经肌肉阻断剂注射之前对福尔科丁暴露的查的临床效用.
- 为了确定这种查是否在过敏预防方面提供实际好处.
主要方法:
- 审查现有的文献和临床指南.
- 对福尔科丁与神经肌肉阻断剂过敏之间所谓的关联的分析.
主要成果:
- 之前使用福尔科丁的查对患者没有明显的实际益处.
- 据称的联系不需要对folcodine进行常规的麻醉前查.
结论:
- 不应阻止麻醉师使用基于folcodine暴露史的神经肌肉阻断剂.
- 临床适应症仍然是神经肌肉阻断剂使用的主要驱动因素,不论是folcodine查.
相关概念视频
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
429
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
429
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.8K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.8K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
454
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
454
Depolarizing Blockers: Mechanism of Action
1.6K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.6K
Drugs Acting on Autonomic Ganglia: Blockers
1.0K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.0K
Depolarizing Blockers: Pharmocokinetics
327
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
327

